PFE
Pfizer Inc.
$28.89+0.06 (+0.21%)Close Nov 13, 2026
Insider trading
12 months to Nov 3, 2026- Net bought
- $2.83M
- Buys less sales
- Bought
- $2.96M
- 3 insiders
- Sold
- $135K
- Jennifer B. Damico
- Latest buy
- Aug 12, 2026
- Albert Bourla
Buys and sales on the price
Since 2003By period
Open-market trades| Trades | 3 months | 12 months | Since 2003 |
|---|---|---|---|
| Buys | 3 | 3 | 22 |
| Sales | 1 | 2 | 215 |
| Plan sales | 0 | 0 | 31 |
| Shares bought | 114,863115K | 114,863115K | 188,614189K |
| Shares sold | 3,2783.28K | 5,2785.28K | 12,137,73312.1M |
| Net shares | +111,585+112K | +109,585+110K | −11,949,119−11.9M |
| Net value | +$2.88M | +$2.83M | −$392M |
Insiders
| Insider | 12 months | Shares held |
|---|---|---|
Albert Bourla Chairman & CEO, Director | +10.2% | 435,555 |
Douglas M. Lankler Executive Vice President | — | 165,260 as of Mar 5, 2026 |
Christoffel Boshoff President, R&D | — | 162,088 as of Mar 5, 2026 |
Cecile Guegan Executive Vice President | — | 149,505 |
Michael McDermott Executive Vice President | — | 74,308 as of Mar 5, 2026 |
Trades
237 trades since 2003| Type | Insider | Role | Shares | Price | Held after | |||
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Buy | Albert BourlaChairman & CEO, Director Chairman & CEO, Director | Chairman & CEO, Director | 38,000 at $26.34 | $26.34 | $1.00M | +9.6% 436K after | 435,555 |
| Aug 5, 2026 | Sale | Jennifer B. DamicoSVP & Controller SVP & Controller | SVP & Controller | 3,278 at $25.40 | $25.40 | $83.3K | −10.3% 28.6K after | 28,611 |
| Aug 5, 2026 | Buy | Ronald E. BlaylockDirector Director | Director | 39,231 at $25.46 | $25.46 | $999K | +120.9% 71.7K after | 71,688 |
| Aug 5, 2026 | Buy | Mortimer J. BuckleyDirector Director | Director | 37,632 at $25.52 | $25.52 | $960K | New 37.6K after | 37,632 |
| Jun 9, 2026 | Sale | Jennifer B. DamicoSVP & Controller SVP & Controller | SVP & Controller | 2,000 at $25.70 | $25.70 | $51.4K | −6.0% Changed by trades not shown: 31.4K after | Changed by trades not shown: 31,397 |
| Mar 4, 2025 | Sale | Jennifer B. DamicoSVP & Controller SVP & Controller | SVP & Controller | 2,500 at $25.93 | $25.93 | $64.8K | −17.4% Changed by trades not shown: 11.8K after | Changed by trades not shown: 11,850 |
| Feb 13, 2025 | Buy | Ronald E. BlaylockDirector Director | Director | 19,457 at $25.65 | $25.65 | $499K | +149.7% 32.5K after | 32,457 |
| Oct 30, 2024 | Buy | Scott GottliebDirector Director | Director | 1,000 at $28.24 | $28.24 | $28.2K | +11.1% 10.0K after | 10,000 |
| Aug 13, 2024 | Sale | Jennifer B. DamicoSVP & Controller SVP & Controller | SVP & Controller | 5,154 at $28.66 | $28.66 | $148K | −37.5% 8.58K after | 8,582 |
| Dec 15, 2023 | Buy | Scott GottliebDirector Director | Director | 3,000 at $26.47 | $26.47 | $79.4K | +50.0% 9.00K after | 9,000 |
- Albert Bourla$1.00MAug 12, 2026 · Buy38,000 at $26.34Chairman & CEO, Director+9.6% of holdings, 436K after
- Jennifer B. Damico$83.3KAug 5, 2026 · Sale3,278 at $25.40SVP & Controller−10.3% of holdings, 28.6K after
- Ronald E. Blaylock$999KAug 5, 2026 · Buy39,231 at $25.46Director+120.9% of holdings, 71.7K after
- Mortimer J. Buckley$960KAug 5, 2026 · Buy37,632 at $25.52DirectorNew holding, 37.6K after
- Jennifer B. Damico$51.4KJun 9, 2026 · Sale2,000 at $25.70SVP & Controller−6.0% of holdings, Changed by trades not shown: 31.4K after
- Jennifer B. Damico$64.8KMar 4, 2025 · Sale2,500 at $25.93SVP & Controller−17.4% of holdings, Changed by trades not shown: 11.8K after
- Ronald E. Blaylock$499KFeb 13, 2025 · Buy19,457 at $25.65Director+149.7% of holdings, 32.5K after
- Scott Gottlieb$28.2KOct 30, 2024 · Buy1,000 at $28.24Director+11.1% of holdings, 10.0K after
- Jennifer B. Damico$148KAug 13, 2024 · Sale5,154 at $28.66SVP & Controller−37.5% of holdings, 8.58K after
- Scott Gottlieb$79.4KDec 15, 2023 · Buy3,000 at $26.47Director+50.0% of holdings, 9.00K after